Karpus Investment Management’s Zura Bio ZURA Stock Holding History

Karpus Investment Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,449	Closed	-$340K	–	397
2022 Q4	$340K	Sell	33,449 -3,750	-10%	-$38K	0.01%	369
2022 Q3	$374K	Sell	37,199 -250	-0.7%	-$2.5K	0.01%	425
2022 Q2	$373K	Hold	37,449	–	–	0.01%	428
2022 Q1	$371K	Buy	+37,449	New	+$369K	0.01%	372

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Karpus Investment Management's ZURA Position: Q1 2023 in Review

Karpus Investment Management sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 33,449 shares — an estimated $340K sold.

Karpus Investment Management first reported a position in ZURA in Q1 2022 and held it in 4 quarters. The position peaked at $374K in Q3 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Karpus Investment Management reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Karpus Investment Management sold 33,449 Zura Bio shares in Q1 2023, an estimated $340K.
Karpus Investment Management first reported a position in Zura Bio in Q1 2022 and held it in 4 quarters.
Karpus Investment Management's Zura Bio position peaked at $374K in Q3 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Karpus Investment Management's 13F filing for Q1 2023, filed 11 May 2023.